fda approval in her2 breast cancer, priority review in nsclc, and more
Published 4 years ago • 123 plays • Length 11:00
Download video MP4
Download video MP3
Similar videos
-
7:28
fda approvals in pml, nsclc, and breast cancer, priority review in dlbcl, and more
-
10:55
fda approvals in cinv and her2 breast cancer, priority review in myelofibrosis, and more
-
6:59
fda approval in nsclc, priority review in bladder cancer, mbcc highlights, and more
-
7:23
fda approval in nsclc, priority review in sclc, 2018 sabcs highlights, and more
-
11:32
fda approvals in breast cancer and nsclc, nda accepted in hcc, and more
-
11:13
fda approval in her2 early breast cancer, fast track designation in tnbc, and more
-
7:18
full fda approvals in breast cancer and lung cancer, priority reviews in all, and more
-
5:35
priority reviews in breast cancer and nsclc, promising results in ovarian cancer, and more
-
9:54
fda approval in nsclc, priority review designation in sclc, crl to biosimilar, and more
-
10:46
fda approval in all, priority reviews in cml and breast cancer, and more
-
9:29
fda approvals in all and breast cancer, priority reviews in cml and follicular lymphoma, and more
-
8:12
fda approvals in hcc, sclc, and nsclc, priority review in rare blood cancer, and more
-
9:27
fda approvals in rcc and cml, priority review designations in nsclc and rcc, and more
-
5:32
fda approval and 2 priority reviews in bladder cancer, and asco's cancer advance of the year
-
19:20
fda-approved therapies for relapsed/refractory her2 mbc
-
9:04
fda approvals in msi-high cancers, priority reviews in gastric cancer and fl, and more
-
9:27
fda approval in bladder cancer, breakthrough therapy designation in dlbcl, and more
-
10:00
fda approval in breast cancer, review period extended in aml, 2019 aacr highlights, and more
-
8:07
fda approval in lung cancer, priority reviews in hcc and nhl, and an odac recommendation
Clip.africa.com - Privacy-policy